Founder Pitches Real-World Data for Healthcare Breakthroughs
May 1, 2024
auto_awesome
Christine Lemke, CEO of Evidation Health, shares the power of real-world data for healthcare breakthroughs. They discuss lessons from Evidation's journey, recruiting diverse participants, accelerating research, and the future of their data platform in changing healthcare.
Real-world data outside clinics enhances healthcare understanding.
Evidation prioritizes diverse participant recruitment in research studies.
Wearable device data offers detailed diagnostics for proactive healthcare interventions.
Deep dives
Founding Inspiration for Evidation
Christine Lemke, co-founder of Evidation, shares her journey of starting the company. Motivated by her own autoimmune condition causing chronic pain over a decade, she realized the need for clear data tracking to facilitate her diagnosis sooner. Initially exploring ideas in sensor data applications for healthcare, the evolution of Evidation's focus stemmed from wellness platforms to real-world data for pharma research.
Patient Data Custodianship
Evidation prioritizes patients' data ownership and control. Christine emphasizes the importance of individuals' rights to their data. The company ensures transparent data usage, allowing individuals to opt-in for compensation opportunities, maintaining respect for privacy and discretion. Evidation's approach differs from data monetization models seen in other sectors, aligning with ethical patient engagement practices.
Diversity in Research Recruitment
Evidation emphasizes diverse participant recruitment in research studies. By leveraging a decentralized model, the platform enhances accessibility for various demographics. The organization focuses on making research inclusive and approachable, employing strategies to engage populations typically hesitant to participate. Active outreach to diverse communities and impactful partnerships aid in broadening the participant pool.
Utilizing Wearable Device Data
The significance of data from wearable devices has grown exponentially. With advancements in device capabilities like heart rate monitoring and AFib detection, data collection has become more detailed and diagnostic. Christine anticipates a future with increasingly rich biometric data sets aiding in early disease detection and personalized interventions. The potential for halting diseases in initial stages excites prospects for improved healthcare outcomes.
Future Directions and Fundraising
Evidation's future goals involve expanding data sources beyond wearables to include molecular data for deeper health insights. The company aims to venture into proactive care solutions and navigate the landscape of funding strategically. Christine emphasizes a balanced approach to fundraising, considering ROI impact and returning value to early supporters. Evidation's commitment to revolutionizing healthcare through data-driven innovations remains steadfast.
In this episode, Christine Lemke, co-founder and CEO of Evidation Health, shares how her personal struggles with chronic pain fueled her mission to transform how we measure and improve health outcomes. She shares the company's evolution and innovative approach to generating real-world evidence (RWE) using a global research platform serving millions of people.
We discuss:
- The power of real-world data and understanding health outside the clinic
- Lessons from pivots: Evidation's journey to its current focus
- How they recruit diverse participants, prioritize consent, and even compensate individuals
- Accelerating research and making it more representative of the populations drugs will actually serve
- Where the company's unique data platform goes next, and how it could change healthcare
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
